Literature DB >> 17465259

Prognostic significance of ezrin expression in pleomorphic malignant fibrous histiocytoma.

Min Suk Kim1, Wan Hyeong Cho, Won Seok Song, Soo-Yong Lee, Dae-Geun Jeon.   

Abstract

BACKGROUND: Newly defined pleomorphic malignant fibrous histiocytoma represents a pleomorphic sarcoma which shows no definable line of differentiation. In this study, the survival and validity of known prognostic factors for patients with pleomorphic MFH, with the possibility of ezrin expression as a new prognostic factor were investigated. PATIENTS AND METHODS: Forty-seven patients without metastasis at presentation were analyzed. Immunohistochemical analysis with anti-ezrin antibody was performed using tissue microarray.
RESULTS: The overall, metastasis-free, and local recurrence-free survival rates were 59%, 57%, 52% at 5 years, respectively. Uni- and multivariate analyses revealed that truncal location and ezrin positivity had negative effects on overall and metastasis-free survival. The independent factors of local recurrence-free survival were narrow surgical margin, truncal location and female gender.
CONCLUSION: Ezrin expression was an independent predictor of distant metastasis in pleomorphic MFH. Thus, ezrin seems to provide additional prognostic information and may be a novel target for the development of new adjuvant therapies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17465259

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

Review 1.  Soft tissue sarcomas with complex genomic profiles.

Authors:  Louis Guillou; Alain Aurias
Journal:  Virchows Arch       Date:  2010-02       Impact factor: 4.064

2.  mTOR regulates the invasive properties of synovial fibroblasts in rheumatoid arthritis.

Authors:  Teresina Laragione; Pércio S Gulko
Journal:  Mol Med       Date:  2010-05-27       Impact factor: 6.354

3.  Evaluation of prognostic factors in localized high-grade undifferentiated pleomorphic sarcoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology.

Authors:  Melike Ozcelik; Mesut Seker; Emrah Eraslan; Sinan Koca; Dogan Yazilitas; Ozlem Ercelep; Ersin Ozaslan; Serap Kaya; Ilhan Hacibekiroglu; Serkan Menekse; Asude Aksoy; Burcu Yapar Taskoylu; Umut Varol; Erkan Arpaci; Aydin Ciltas; Berna Oksuzoglu; Nurullah Zengin; Mahmut Gumus; Mehmet Aliustaoglu
Journal:  Tumour Biol       Date:  2015-11-10

4.  High expression of EZR (ezrin) gene is correlated with the poor overall survival of breast cancer patients.

Authors:  Rongju Zhang; Shaohui Zhang; Rongge Xing; Qin Zhang
Journal:  Thorac Cancer       Date:  2019-08-26       Impact factor: 3.500

5.  The clinical prognostic significance of ezrin in patients with bone and soft tissue sarcomas: a meta-analysis.

Authors:  Feng Wang; Tao Yu; Chengbin Ma; Haifei Zhang; Zhiyu Zhang
Journal:  FEBS Open Bio       Date:  2019-09-03       Impact factor: 2.693

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.